oxaliplatin,sintilimab,capecitabine
eli lilly,innovent biologics
['sintilimab', 'orient-16', 'gastric', 'innovent']
innovent releases final analysis results of orient-16: the phase 3 study of sintilimab in combination with chemotherapy for the first-line treatment of gastric cancer at the aacr annual meeting 2023 
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people.